DS
Dasappa Subramanyam
About Dasappa Subramanyam
Data last updated:
Dasappa Subramanyam is a Director at Acinonyx Pharmaceutical Private Limited (since 2020) and Director at Lionel Healthcare Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Acinonyx Pharmaceutical Private Limited at ₹2.2 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Jan 2020 | 2020 | ₹2.2 Lakh (FY 2023) | Active | |
| Director | 06 Jun 2023 | 2023 | Active |
Board colleagues of Dasappa Subramanyam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kannaiah Hemanth Kumar | 09448488 | Acinonyx Pharmaceutical Private Limited | Director |
| Nagaveni Nagaraju | 10192820 | Lionel Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dasappa Subramanyam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dasappa Subramanyam
Dasappa Subramanyam currently holds 2 directorships: Acinonyx Pharmaceutical Private Limited (Director, since 07 Jan 2020, revenue ₹2.2 Lakh (FY 2023)); Lionel Healthcare Private Limited (Director, since 06 Jun 2023).
Dasappa Subramanyam was first appointed on 07 Jan 2020 as Director at Acinonyx Pharmaceutical Private Limited. The most recent appointment on record is 06 Jun 2023 at Lionel Healthcare Private Limited.
The current boards of Dasappa Subramanyam's companies include Kannaiah Hemanth Kumar (Acinonyx Pharmaceutical Private Limited), Nagaveni Nagaraju (Lionel Healthcare Private Limited).